| JPX Exchange | US Country |
BGM Group Ltd is a prominent name in the pharmaceutical industry, focused on the manufacturing and distribution of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and various by-products within China. Established in 2019 and initially known as Qilian International Holding Group Limited, the company made a strategic name change to BGM Group Ltd in October 2024. Headquartered in Chengdu, People's Republic of China, BGM Group has carved a niche for itself by providing an extensive range of products that cater to both medical and agricultural industries. The company prides itself on blending traditional Chinese medicine with modern pharmaceutical practices to offer innovative solutions for healthcare and agriculture.